Drug intelligence / Profile preview

gadolinium oxide nanoparticles

Development stage
Preclinical
Lead developer
University of Texas at Austin
Modality
Nanoparticles → Drug Delivery Systems
Administration
Implant
01

Overview

Gadolinium oxide nanoparticles (Gd2O3 NPs) are inorganic nanomaterials utilized as high-performance contrast agents for magnetic resonance imaging (MRI). They leverage the high paramagnetic moment of gadolinium ions (Gd3+) to shorten the T1 relaxation time of surrounding water protons, thereby enhancing signal intensity in T1-weighted images. In clinical research, these nanoparticles are being explored for various applications, including targeted imaging of tumors and as components in medical devices to improve visibility under MRI guidance. Specifically, research at The University of Texas at Austin has evaluated their use in polyimide resins to enhance the visibility of microneedles used in convection-enhanced delivery (CED) systems for treating glioblastoma.

Other names
Gd2O3 nanoparticlesGd-2O3 nanoparticlesGd 2O3 nanoparticlesgadolinium(III) oxide nanoparticles

Beyond the preview

Go deeper on gadolinium oxide nanoparticles.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gadolinium oxide nanoparticles.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call